- Home
- Publications
- Publication Search
- Publication Details
Title
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 9, Pages 2164
Publisher
MDPI AG
Online
2019-05-02
DOI
10.3390/ijms20092164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways
- (2018) Fan Tang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy
- (2018) Michael Mutlak et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hypertrophic cardiomyopathy mutations increase myofilament Ca2+buffering, alter intracellular Ca2+handling, and stimulate Ca2+-dependent signaling
- (2018) Paul Robinson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondrial ROS-induced ERK1/2 activation and HSF2-mediated AT1 R upregulation are required for doxorubicin-induced cardiotoxicity
- (2017) Chih-Yang Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy
- (2017) Chih-Yang Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Activation of IGF-1 receptors and Akt signaling by systemic hyperinsulinemia contributes to cardiac hypertrophy but does not regulate cardiac autophagy in obese diabetic mice
- (2017) Karla Maria Pires et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice
- (2017) Che-Chung Yeh et al. PLoS One
- Icariin attenuated oxidative stress induced-cardiac apoptosis by mitochondria protection and ERK activation
- (2016) Yao-Hong Song et al. BIOMEDICINE & PHARMACOTHERAPY
- Trastuzumab cardiotoxicity: from clinical trials to experimental studies
- (2016) Balazs T Nemeth et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy
- (2016) Jennifer Davis et al. CELL
- Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
- (2016) Kesong Peng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib
- (2016) Valentina Sala et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Analyzing ERK 1/2 signalling and targets
- (2016) Alexandra Brietz et al. Molecular BioSystems
- Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes
- (2016) Nishant Mohan et al. MOLECULAR CANCER THERAPEUTICS
- Scaffold Proteins Regulating Extracellular Regulated Kinase Function in Cardiac Hypertrophy and Disease
- (2016) Yan Liang et al. Frontiers in Pharmacology
- Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway
- (2016) Chen Li et al. PLoS One
- Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy
- (2015) Lin Zhong et al. CARDIOVASCULAR RESEARCH
- Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes
- (2015) MI-HUA LIU et al. Molecular Medicine Reports
- Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt
- (2015) Shu-Fang He et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
- (2015) Luc Rochette et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cardiac-targeting magnetic lipoplex delivery of SH-IGF1R plasmid attenuate norepinephrine-induced cardiac hypertrophy in murine heart
- (2014) Yiping Xu et al. BIOSCIENCE REPORTS
- Inherited Cardiomyopathies
- (2014) Jeffrey A. Towbin CIRCULATION JOURNAL
- Doxorubicin and Trastuzumab Regimen Induces Biventricular Failure in Mice
- (2014) Giuseppina Milano et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- The Muscle Ankyrin Repeat Proteins CARP, Ankrd2, and DARP Are Not Essential for Normal Cardiac Development and Function at Basal Conditions and in Response to Pressure Overload
- (2014) Marie-Louise Bang et al. PLoS One
- Erbin is a negative modulator of cardiac hypertrophy
- (2014) I. Rachmin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Met signaling in cardiomyocytes is required for normal cardiac function in adult mice
- (2013) María Arechederra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy
- (2013) Sarah N. Cilvik et al. PLoS One
- Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy
- (2013) C. Ruppert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway
- (2012) Marie Vidal et al. CARDIOVASCULAR RESEARCH
- The Dual-Targeted HER1/HER2 Tyrosine Kinase Inhibitor Lapatinib Strongly Potentiates the Cardiac Myocyte-Damaging Effects of Doxorubicin
- (2012) Brian B. Hasinoff et al. Cardiovascular Toxicology
- Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK
- (2012) Yen-Ling Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Loss of Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells and Cardiomyocytes Causes Arterial Hypotension and Cardiac Hypertrophy
- (2012) Barbara Schreier et al. HYPERTENSION
- β2-AR-induced Her2 transactivation mediated by Erbin confers protection from apoptosis in cardiomyocytes
- (2012) Ming Shi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Unknown
- (2012) Valentina Sala et al. MOLECULAR MEDICINE
- Molecular basis of physiological heart growth: fundamental concepts and new players
- (2012) Marjorie Maillet et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cardiac-Specific Over-Expression of Epidermal Growth Factor Receptor 2 (ErbB2) Induces Pro-Survival Pathways and Hypertrophic Cardiomyopathy in Mice
- (2012) Polina Sysa-Shah et al. PLoS One
- Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
- (2011) Eric Reiter et al. Annual Review of Pharmacology and Toxicology
- IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload
- (2011) Mauro Sbroggiò et al. CARDIOVASCULAR RESEARCH
- Morgana and melusin: Two fairies chaperoning signal transduction
- (2011) Roberta Ferretti et al. CELL CYCLE
- MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation
- (2011) Xue Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease
- (2011) Christian Leo et al. PLoS One
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
- (2010) Izhak Kehat et al. CIRCULATION
- Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response and Promotes Pressure Overload–Induced Apoptosis in the Heart
- (2010) Tomomi E. Kimura et al. CIRCULATION RESEARCH
- Molecular and clinical analysis ofRAF1in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation
- (2010) Tomoko Kobayashi et al. HUMAN MUTATION
- Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation
- (2010) Zhuo Zhao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure
- (2009) Xiao-Mei Li et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Protein scaffolds in MAP kinase signalling
- (2008) Matthew D. Brown et al. CELLULAR SIGNALLING
- Deletion of Ptpn11 (Shp2) in Cardiomyocytes Causes Dilated Cardiomyopathy via Effects on the Extracellular Signal–Regulated Kinase/Mitogen-Activated Protein Kinase and RhoA Signaling Pathways
- (2008) Maria I. Kontaridis et al. CIRCULATION
- Beta-Arrestin-Mediated Signaling in the Heart
- (2008) Priyesh A. Patel et al. CIRCULATION JOURNAL
- An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice
- (2008) Farah Sheikh et al. JOURNAL OF CLINICAL INVESTIGATION
- A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
- (2008) Kristina Lorenz et al. NATURE MEDICINE
- Cardiac Plasticity
- (2008) Joseph A. Hill et al. NEW ENGLAND JOURNAL OF MEDICINE
- -Blockers alprenolol and carvedilol stimulate -arrestin-mediated EGFR transactivation
- (2008) I.-M. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation